Literature DB >> 18498265

Incidental prostate cancer in patients undergoing radical cystoprostatectomy for bladder cancer.

Mustafa Hiros1, Hajrudin Spahović, Mirsad Selimović, Sabina Sadović.   

Abstract

The objective of this work is to verify the incidence of incidental prostate adenocarcinoma in patients who underwent radical cystoprostatectomy for invasive bladder carcinoma. We have retrospectively reviewed patients who underwent radical cystoprostatectomy for infiltrative bladder tumors in period between 2003 and 2007 year, 94 men with bladder cancer underwent radical cystoprostatectomy at Urology Clinic-University of Sarajevo Clinics Centre. Mean age of patients was 67 years, with age limits ranging between 48 and 79 years. Pathohistological evaluation was used for all specimens from RCP. We found that 9,57% of cystoprostatectomy specimens in patients with bladder cancer also contained incidental prostate cancer. This result was much lower than overall mean frequency of incidentally detected prostate cancer in other series of cystoprostatectomy cases (range, 23%-68%). In conclusion we recommended digital rectal examination (DRE) and prostate-specific antigen (PSA) test as part of the bladder cancer work up and complete removal of the prostate at cystoprostatectomy to prevent residual prostate cancer.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18498265      PMCID: PMC5698345          DOI: 10.17305/bjbms.2008.2970

Source DB:  PubMed          Journal:  Bosn J Basic Med Sci        ISSN: 1512-8601            Impact factor:   3.363


  13 in total

1.  Incidental prostatic adenocarcinoma in patients undergoing radical cystoprostatectomy for bladder cancer.

Authors:  F Abbas; D Hochberg; F Civantos; M Soloway
Journal:  Eur Urol       Date:  1996       Impact factor: 20.096

2.  Synchronous primary carcinomas of the bladder and prostate.

Authors:  Sheng-Hui Lee; Phei-Lang Chang; Shao-Ming Chen; Guang-Huan Sun; Chien-Lun Chen; Biing-Yir Shen; Ya-Shen Wu; Ke-Hung Tsui
Journal:  Asian J Androl       Date:  2006-05       Impact factor: 3.285

3.  [Clinical analysis of double cancer involving bladder and prostate].

Authors:  Yasushi Yumura; Yoshiharu Oogo; Kazunori Takase; Yoshitake Kato; Atsushi Hamano; Sumio Noguchi; Momokuni Fukuda; Yoshiaki Satomi
Journal:  Hinyokika Kiyo       Date:  2006-04

4.  Adenocarcinoma of the prostate in cystoprostatectomy specimens removed for bladder cancer.

Authors:  J E Montie; D P Wood; J E Pontes; J M Boyett; H S Levin
Journal:  Cancer       Date:  1989-01-15       Impact factor: 6.860

5.  Some characteristics of multiple primary cancers.

Authors:  W L Mersheimer; A Ringel; H Eisenberg
Journal:  Ann N Y Acad Sci       Date:  1964-04-02       Impact factor: 5.691

6.  Clinically significant prostate cancer found incidentally in radical cystoprostatectomy specimens.

Authors:  Mazen Abdelhady; Ashraf Abusamra; Stephen E Pautler; Joseph L Chin; Jonathan I Izawa
Journal:  BJU Int       Date:  2006-10-09       Impact factor: 5.588

7.  Incidentally detected prostate cancer in cystoprostatectomy specimens.

Authors:  C Kouriefs; T Fazili; S Masood; M S Naseem; G R Mufti
Journal:  Urol Int       Date:  2005       Impact factor: 2.089

8.  Should prostate cancer status be determined in patients undergoing radical cystoprostatectomy?

Authors:  Oner Sanli; Omer Acar; Murad Celtik; Tayfun Oktar; Isin Kilicaraslan; Faruk Ozcan; Murat Tunc; Tarik Esen
Journal:  Urol Int       Date:  2006       Impact factor: 2.089

Review 9.  Early detection of prostate cancer.

Authors:  P T Scardino; R Weaver; M A Hudson
Journal:  Hum Pathol       Date:  1992-03       Impact factor: 3.466

10.  Incidence and location of prostate and urothelial carcinoma in prostates from cystoprostatectomies: implications for possible apical sparing surgery.

Authors:  Monica P Revelo; Michael S Cookson; Sam S Chang; M Frances Shook; Joseph A Smith; Scott B Shappell
Journal:  J Urol       Date:  2004-02       Impact factor: 7.450

View more
  1 in total

1.  Prostatic carcinoma bilateral iris metastases.

Authors:  Tatjana S Sarenac; Mirjana A Janicijevic-Petrovic; Suncica B Sreckovic; Milan R Radovanovic; Dejan D Vulovic; Katarina M Janicijevic
Journal:  Bosn J Basic Med Sci       Date:  2012-05       Impact factor: 3.363

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.